期刊
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
卷 104, 期 -, 页码 90-96出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbb.2012.12.014
关键词
Chembridge-5861528; Clonidine; Conditioned place-preference; Diabetic neuropathy; Mechanical hypersensitivity; Ongoing pain; Peripheral nerve injury; Transient receptor potential ankyrin 1 channel
资金
- pharmaceutical company (OrionPharma, Finland)
- Portuguese Science Foundation (FCT) [SFRH/BD/71219/2010]
- Sigrid Juselius Foundation, Helsinki
- Academy of Finland, Helsinki
- OrionPharma, Orion Corporation, Turku, Finland
- Fundação para a Ciência e a Tecnologia [SFRH/BD/71219/2010] Funding Source: FCT
Transient receptor potential ankyrin 1 (TRPA1) channel antagonists have suppressed mechanical hypersensitivity in peripheral neuropathy, while their effect on ongoing neuropathic pain is not yet known. Here, we assessed whether blocking the TRPA1 channel induces place-preference, an index for the relief of ongoing pain, in two experimental rat models of peripheral neuropathy. Diabetic neuropathy was induced by streptozotocin and spared nerve injury (SNI) model of neuropathy by ligation of two sciatic nerve branches. Conditioned place-preference (CPP) paradigm involved pairing of the drug treatment with one of the chambers of a CPP device once or four times, and the time spent in each chamber was recorded after conditioning sessions to reveal place-preference. The mechanical antihypersensitivity effect was assessed by the monofilament test immediately after the conditioning sessions. Intraperitoneally (30 mg/kg; diabetic and SNI model) or intrathecally (10 mu g; diabetic model) administered Chembridge-5861528 (CHEM) was used as a selective TRPA1 channel antagonist. In diabetic and SNI models of neuropathy, CHEM failed to induce CPP at a dose that significantly attenuated mechanical hypersensitivity, independent of the route of drug administration or number of successive conditioning sessions. Intrathecal clonidine (an alpha(2)-adrenoceptor agonist; 10 mu g), in contrast induced CPP in SNI but not control animals. The results indicate that ongoing pain, as revealed by CPP, is less sensitive to treatment by the TRPA1 channel antagonist than mechanical hypersensitivity in peripheral neuropathy. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据